Imidazole → HCID 67257102, compound
Reaction equation
CC1(C)[O:6][CH:5]([C:7]2[CH:12]=[CH:11][N:10]=[C:9]([NH2:13])[N:8]=2)[CH2:4][O:3]1.O.C1(C)C=CC(S(O)(=O)=O)=CC=1.N1C=CN=C1.[Si:32](Cl)([C:35]([CH3:38])([CH3:37])[CH3:36])([CH3:34])[CH3:33]>CO.CN(C)C=O>[NH2:13][C:9]1[N:8]=[C:7]([CH:5]([OH:6])[CH2:4][O:3][Si:32]([C:35]([CH3:38])([CH3:37])[CH3:36])([CH3:34])[CH3:33])[CH:12]=[CH:11][N:10]=1Participants
7
Procedure
To a solution of 4-(2,2-dimethyl-1,3-dioxolan-4-yl)pyrimidin-2-amine (2f) (7.18 g) in methanol (300 mL) was added p-toluenesulfonic acid monohydrate (10.49 g) and the solution was stirred at room temperature overnight. The mixture was filtered through sodium carbonate and concentrated under vacuum to give a brown solid that was dissolved in N,N-dimethylformamide (400 mL) to which was added imidazole (5.2 g) and tert-butyldimethylsilyl chloride (7.7 g) and the solution was stirred at room temperature overnight. The mixture was concentrated on silica under vacuum and purified by silica flash chromatography eluting with 50% to 75% ethyl acetate in heptane to give the title compound (850 mg).
Workup
- filtrationThe mixture was filtered through sodium carbonate
- concentrationconcentrated under vacuum
- customto give a brown solid that
- stirringthe solution was stirred at room temperature overnight
- concentrationThe mixture was concentrated on silica under vacuum
- custompurified by silica flash chromatography
- washeluting with 50% to 75% ethyl acetate in heptane
Sources & evidence
- ORD record
- ord-63124ca53e4947948c870c0874eeb8d5
- Source dataset
- uspto-grants-2015_02
- Patent number
- US08952001B2
Reaction notes
Loading…